找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu

[復(fù)制鏈接]
樓主: Animosity
41#
發(fā)表于 2025-3-28 14:53:37 | 只看該作者
Einführung in die theoretische Gasdynamikin practical clinical science. Substitutive administration of a new concentrate of a human immunoglobulin (IgG) preparation resulted in regular minimal platelet increases in a child with a primary immunodeficiency and low platelet counts despite normal platelet production. The investigators conclude
42#
發(fā)表于 2025-3-28 22:41:14 | 只看該作者
Einführung in die theoretische Gasdynamikestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and
43#
發(fā)表于 2025-3-28 23:11:57 | 只看該作者
44#
發(fā)表于 2025-3-29 04:24:39 | 只看該作者
Kapitel 7: Erfassung sozialer Ph?nomeneoimmune syndromes. Although the precise mechanism of action of IVIg as an immunomodulatory agent has been elusive, many theories over the years have been postulated. These theories include mononuclear phagocytic system blockade, autoantibody neutralization, increased clearance of pathogenic autoanti
45#
發(fā)表于 2025-3-29 08:53:31 | 只看該作者
46#
發(fā)表于 2025-3-29 15:11:12 | 只看該作者
Kapitel 10: Theorien der Gegenwartously untreatable, or poorly managed, conditions. Based on controlled trials, IVIg is approved as first-line therapy for patients with GBS, CIDP, and multifocal motor neuropathy. In CIDP, where the largest controlled study was performed, IVIg is also effective in the chronic management of the diseas
47#
發(fā)表于 2025-3-29 18:47:07 | 只看該作者
Kapitel 6: Grundbegriffe und Datenerhebungwhen Furusho et al. (1984) and Newburger et al. (1986), respectively, reported the successful application of IVIg in Kawasaki syndrome. Seven years later, Dalakas et al. (1993) reported the first successful randomized controlled trial of IVIg in the treatment of dermatomyositis. Ever since, IVIg has
48#
發(fā)表于 2025-3-29 23:13:03 | 只看該作者
49#
發(fā)表于 2025-3-30 02:25:00 | 只看該作者
50#
發(fā)表于 2025-3-30 04:39:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 18:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
和政县| 阳曲县| 宁城县| 高台县| 衡水市| 安乡县| 靖边县| 工布江达县| 宣恩县| 伊春市| 肇源县| 陇西县| 崇阳县| 西青区| 商城县| 泊头市| 肇庆市| 海盐县| 资阳市| 大悟县| 乌什县| 富顺县| 合江县| 德令哈市| 米林县| 上饶市| 洮南市| 阜康市| 莱西市| 拉萨市| 连城县| 平凉市| 临夏市| 顺义区| 新余市| 永仁县| 双桥区| 股票| 逊克县| 清徐县| 轮台县|